Alias: VELCADE; dpba; [(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid; VELCADE(BORTEZOMIB); Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-; Bortezomib for research; N-[(1S)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-D-phenylalaninamide; N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide; Bortizomib

English name: Bortezomib;

Appearance: white powder;

Purity: 99.50%;

Molecular weight: 384.2372;

Molecular formula:C19H25BN4O4;

CAS RN: 179324-69-7;

Packaging: 100G/alumnium bag;1KG/bag,5KG/drum,10KG/drum,25KG/drum;

Uses: treatment of malignant tumor

【Back】